Increase in the circulating endocannabinoid 2-arachidonoylglycerol is associated with gabapentin use in septic ICU patients

Endocrine. 2017 Oct;58(1):203-204. doi: 10.1007/s12020-017-1399-x. Epub 2017 Sep 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • APACHE
  • Aged
  • Aged, 80 and over
  • Amines / adverse effects*
  • Amines / therapeutic use
  • Analgesics / adverse effects*
  • Analgesics / therapeutic use
  • Arachidonic Acids / blood*
  • Critical Care
  • Critical Illness
  • Cyclohexanecarboxylic Acids / adverse effects*
  • Cyclohexanecarboxylic Acids / therapeutic use
  • Endocannabinoids / blood*
  • Female
  • Gabapentin
  • Glycerides / blood*
  • Humans
  • Intensive Care Units
  • Male
  • Middle Aged
  • Sepsis / blood*
  • gamma-Aminobutyric Acid / adverse effects*
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • Amines
  • Analgesics
  • Arachidonic Acids
  • Cyclohexanecarboxylic Acids
  • Endocannabinoids
  • Glycerides
  • gamma-Aminobutyric Acid
  • Gabapentin
  • glyceryl 2-arachidonate